4503 — Astellas Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual balance sheet for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	326,128	318,267	376,946	335,780	189,876
Net Total Accounts Receivable
Net Total Receivables	362,722	423,018	465,455	576,726	674,653
Total Inventory
Total Other Current Assets
Total Current Assets	872,588	923,354	1,049,954	1,194,730	1,201,349
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	264,623	269,044	286,459	293,742	328,921
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,273,628	2,332,395	2,456,518	3,569,603	3,339,544
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	592,372	687,411	726,034	1,285,725	1,061,610
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	887,513	872,087	948,564	1,973,615	1,826,289
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,386,115	1,460,308	1,507,954	1,595,988	1,513,255
Total Liabilities & Shareholders' Equity	2,273,628	2,332,395	2,456,518	3,569,603	3,339,544
Total Common Shares Outstanding